Levin Capital Strategies, L.P. Renalytix PLC Transaction History
Levin Capital Strategies, L.P.
- $1.03 Billion
- Q3 2024
A detailed history of Levin Capital Strategies, L.P. transactions in Renalytix PLC stock. As of the latest transaction made, Levin Capital Strategies, L.P. holds 555,000 shares of RNLX stock, worth $83,250. This represents 0.01% of its overall portfolio holdings.
Number of Shares
555,000
Previous 555,000
-0.0%
Holding current value
$83,250
Previous $127,000
8.66%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding RNLX
# of Institutions
29Shares Held
3.91MCall Options Held
13.7KPut Options Held
0-
Pinnacle Associates LTD847KShares$126,9800.0% of portfolio
-
Tejara Capital LTD London, X0499KShares$74,8650.05% of portfolio
-
Stifel Financial Corp St. Louis, MO489KShares$73,4140.0% of portfolio
-
Ci Private Wealth, LLC Miami, FL336KShares$50,3270.0% of portfolio
-
Ubs Group Ag280KShares$41,9610.0% of portfolio
About Renalytix plc
- Ticker RNLX
- Exchange OTC
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 37,445,900
- Market Cap $5.62M
- Description
- Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...